{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:51:24Z","timestamp":1758477084111,"version":"3.40.5"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Theoretical Population Biology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.tpb.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T12:45:14Z","timestamp":1473425114000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-3379","authenticated-orcid":false,"given":"Ashish","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tpb.2016.08.004_br000005","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/S0140-6736(09)60744-3","article-title":"Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol","volume":"373","author":"Anderson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tpb.2016.08.004_br000010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mbs.2009.12.006","article-title":"Cost-effective control of chronic viral diseases: finding the optimal level of screening and contact tracing","volume":"224","author":"Armbruster","year":"2010","journal-title":"Math. Biosci."},{"key":"10.1016\/j.tpb.2016.08.004_br000015","doi-asserted-by":"crossref","first-page":"19884","DOI":"10.7448\/IAS.18.1.19884","article-title":"Homosexual men in HIV serodiscordant relationships: implications for HIV treatment as prevention research","volume":"18","author":"Bavinton","year":"2015","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.tpb.2016.08.004_br000020","series-title":"Modern Concepts of Acute and Chronic Hepatitis","first-page":"113","article-title":"Hepatitis delta virus in acute and chronic liver disease","author":"Bonino","year":"1989"},{"key":"10.1016\/j.tpb.2016.08.004_br000025","unstructured":"Bureau of Democracy, 2010., H. R., AND LABOR, 2009 Human Rights Report: China (includes Tibet, Hong Kong, and Macau)."},{"key":"10.1016\/j.tpb.2016.08.004_br000030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2893.2010.01324.x","article-title":"Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study","volume":"18","author":"Buti","year":"2011","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.tpb.2016.08.004_br000035","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2012.12-0083","article-title":"Epidemiology and molecular characterization of hepatitis b virus infection in isolated villages in the Western Brazilian Amazon","volume":"87","author":"Castilho","year":"2012","journal-title":"Amer. J. Trop. Med. Hyg."},{"key":"10.1016\/j.tpb.2016.08.004_br000040","unstructured":"Constantin, S., 2015. STD Statistics."},{"key":"10.1016\/j.tpb.2016.08.004_br000045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/014107680409700703","article-title":"Diagnosis and treatment of chronic hepatitis B","volume":"97","author":"D\u2019Souza","year":"2004","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.tpb.2016.08.004_br000050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.50.4.443","article-title":"Combination therapy for hepatitis B","volume":"50","author":"Di Bisceglie","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.tpb.2016.08.004_br000055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3949\/ccjm.75a.07019","article-title":"Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis","volume":"75","author":"Elgouhari","year":"2008","journal-title":"Cleve Clin. J. Med."},{"key":"10.1016\/j.tpb.2016.08.004_br000060","unstructured":"Foundation, A.L., 2014. The Campaign for The Cure Case for Support. Vol. 2014, New York."},{"key":"10.1016\/j.tpb.2016.08.004_br000065","doi-asserted-by":"crossref","first-page":"e110143","DOI":"10.1371\/journal.pone.0110143","article-title":"The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology","volume":"9","author":"Goyal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tpb.2016.08.004_br000070","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jval.2012.06.005","article-title":"Cost-effectiveness analysis of antiviral treatments for HBeAg-positive chronic hepatitis B in Canada","volume":"15","author":"He","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.tpb.2016.08.004_br000075","unstructured":"Hertog, S.M., \u00a0, M.G., 2007. Demographic shifts and the spread of HIV in China. 2007 annual meeting of the Population Association of America, New York City."},{"key":"10.1016\/j.tpb.2016.08.004_br000080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7150\/ijms.2.50","article-title":"Epidemiology and prevention of hepatitis B virus infection","volume":"2","author":"Hou","year":"2005","journal-title":"Int. J. Med. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.tpb.2016.08.004_br000085","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1007\/s10461-013-0645-3","article-title":"Population-based sexual behavior surveys in China: Liuzhou compared with other prefectural cities","volume":"18","author":"Huang","year":"2014","journal-title":"AIDS Behav."},{"key":"10.1016\/j.tpb.2016.08.004_br000090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.tpb.2016.08.004_br000095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S0266462312000736","article-title":"Should chronic hepatitis B be treated as early as possible?","volume":"29","author":"Hulstaert","year":"2013","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"10.1016\/j.tpb.2016.08.004_br000100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hep.23310","article-title":"Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China","volume":"51","author":"Hutton","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.tpb.2016.08.004_br000105","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/475451","article-title":"Mathematical modeling of transmission dynamics and optimal control of vaccination and treatment for hepatitis B virus","volume":"2014","author":"Kamyad","year":"2014","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.tpb.2016.08.004_br000110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mbs.2009.11.009","article-title":"The impact of information transmission on epidemic outbreaks","volume":"225","author":"Kiss","year":"2010","journal-title":"Math. Biosci."},{"key":"10.1016\/j.tpb.2016.08.004_br000115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jtbi.2010.04.003","article-title":"Optimal control for pandemic influenza: The role of limited antiviral treatment and isolation","volume":"265","author":"Lee","year":"2010","journal-title":"J. Theoret. Biol."},{"key":"10.1016\/j.tpb.2016.08.004_br000120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/0003-4819-156-4-201202210-00005","article-title":"New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis","volume":"156","author":"Liu","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tpb.2016.08.004_br000125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10887-008-9029-3","article-title":"Death and development","volume":"13","author":"Lorentzen","year":"2008","journal-title":"J. Econ. Growth."},{"key":"10.1016\/j.tpb.2016.08.004_br000130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1472-6963-13-37","article-title":"Direct economic burden of hepatitis B virus related diseases: evidence from Shandong China","volume":"13","author":"Lu","year":"2013","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.tpb.2016.08.004_br000135","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.vaccine.2013.01.020","article-title":"Economic evaluation of universal newborn hepatitis B vaccination in China","volume":"31","author":"Lu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tpb.2016.08.004_br000140","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.3748\/wjg.v11.i45.7179","article-title":"Histological outcome of chronic hepatitis B in children treated with interferon alpha","volume":"11","author":"Maria Elzbieta","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tpb.2016.08.004_br000145","doi-asserted-by":"crossref","first-page":"e22309","DOI":"10.1371\/journal.pone.0022309","article-title":"Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users","volume":"6","author":"Martin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tpb.2016.08.004_br000150","unstructured":"Ministry of Finance, C., 2015. Report on China\u2019s central, local budgets."},{"key":"10.1016\/j.tpb.2016.08.004_br000155","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jtbi.2010.05.038","article-title":"Dynamical behavior of a hepatitis B virus transmission model with vaccination","volume":"265","author":"Pang","year":"2010","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.tpb.2016.08.004_br000160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/liv.12060","article-title":"Optimal management of HBV infection during pregnancy","volume":"33","author":"Piratvisuth","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.tpb.2016.08.004_br000165","unstructured":"Prevention, C. f. D. C. a., 2009. Hepatitis B information for the public."},{"key":"10.1016\/j.tpb.2016.08.004_br000170","unstructured":"Prevention, C. f. D. C. a., 2016. Vaccines for Children Program (VFC)."},{"key":"10.1016\/j.tpb.2016.08.004_br000175","series-title":"Fields Virology","first-page":"2819","article-title":"Hepatitis Delta virus","author":"Purcell","year":"1996"},{"key":"10.1016\/j.tpb.2016.08.004_br000180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","article-title":"Hepatitis B virus infection: epidemiology and vaccination","volume":"28","author":"Shepard","year":"2006","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.tpb.2016.08.004_br000185","unstructured":"Sisters, \u00a0, et al. 2010. HIV\/HCV Co-infection: Planning The Way Forward. 1st South and Southeast Asia Regional Community Meeting, Bangkok, Thailand."},{"key":"10.1016\/j.tpb.2016.08.004_br000190","unstructured":"The World Bank, 2013. Pregnant women receiving prenatal care. The World Bank."},{"key":"10.1016\/j.tpb.2016.08.004_br000195","first-page":"46","article-title":"Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China","author":"Toy","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.tpb.2016.08.004_br000200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vhri.2012.03.008","article-title":"Cost of illness of chronic hepatitis B infection in vietnam","volume":"1","author":"Tu","year":"2012","journal-title":"Value Health Regional Issues"},{"key":"10.1016\/j.tpb.2016.08.004_br000205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrgastro.2009.205","article-title":"Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead","volume":"7","author":"Wedemeyer","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tpb.2016.08.004_br000210","unstructured":"WHO, 2001. Hepatitis delta. In: D. o. C. D. S. a. Response, (Ed.)."},{"key":"10.1016\/j.tpb.2016.08.004_br000215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0950268800058970","article-title":"The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes","volume":"116","author":"Williams","year":"1996","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.tpb.2016.08.004_br000220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/1472-6963-12-385","article-title":"Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China","volume":"12","author":"Wu","year":"2012","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.tpb.2016.08.004_br000225","doi-asserted-by":"crossref","first-page":"e5247","DOI":"10.1371\/journal.pone.0005247","article-title":"How hepatitis D virus can hinder the control of hepatitis B virus","volume":"4","author":"Xiridou","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tpb.2016.08.004_br000230","first-page":"15","article-title":"Epidemiology of hepatitis B virus infection in China: Current status and challenges","volume":"2","author":"Yan","year":"2014","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.tpb.2016.08.004_br000235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1665-2681(19)31565-0","article-title":"The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: A systematic review and meta-analysis","volume":"10","author":"Yi","year":"2011","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.tpb.2016.08.004_br000240","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ije\/29.4.744","article-title":"A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China","volume":"29","author":"Zhao","year":"2000","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.tpb.2016.08.004_br000245","first-page":"98","article-title":"Vaccination against hepatitis B: the Chinese experience","volume":"122","author":"Zhou","year":"2009","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.tpb.2016.08.004_br000250","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3934\/mbe.2013.10.1691","article-title":"Optimal isolation strategies of emerging infectious diseases with limited resources","volume":"10","author":"Zhou","year":"2013","journal-title":"Math. Biosci. Eng."},{"key":"10.1016\/j.tpb.2016.08.004_br000255","unstructured":"Zobair, M.Y., et al. 2015. The Impact of Sustained Viral Eradication on the Work Productivity of Patients with Chronic Hepatitis C (CHC) from the Five European Countries and the United States. Digestive Disease Week 2015, Washington DC."},{"key":"10.1016\/j.tpb.2016.08.004_br000260","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1137\/090777645","article-title":"An age-structured model for the transmission dynamics of hepatitis B","volume":"70","author":"Zou","year":"2010","journal-title":"SIAM J. Appl. Math."},{"key":"10.1016\/j.tpb.2016.08.004_br000265","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jtbi.2009.09.035","article-title":"Modeling the transmission dynamics and control of hepatitis B virus in China","volume":"262","author":"Zou","year":"2010","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.tpb.2016.08.004_br000270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2015.01.005","article-title":"On the sexual transmission dynamics of hepatitis B virus in China","volume":"369","author":"Zou","year":"2015","journal-title":"J. Theoret. Biol."}],"container-title":["Theoretical Population Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040580916300466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040580916300466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T15:53:01Z","timestamp":1572623581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040580916300466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":54,"alternative-id":["S0040580916300466"],"URL":"https:\/\/doi.org\/10.1016\/j.tpb.2016.08.004","relation":{},"ISSN":["0040-5809"],"issn-type":[{"type":"print","value":"0040-5809"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication","name":"articletitle","label":"Article Title"},{"value":"Theoretical Population Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tpb.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}